Technical Analysis for CRXM - Taxus Cardium Pharmaceuticals Group, Inc

Grade Last Price % Change Price Change
grade B 0.15 0.00% 0.0000
CRXM closed unchanged on Friday, January 24, 2020, on 79 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Down Down
Historical CRXM trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
200 DMA Support Bullish 0.00%
Overbought Stochastic Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Older signals for CRXM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Taxus Cardium Pharmaceuticals Group Inc. is engaged in managing a medical technologies portfolio of equity-based and potential royalty-driven investments. The Company's portfolio includes Angionetics, Inc. (Angionetics); Activation Therapeutics, Inc. (Activation Therapeutics); LifeAgain Insurance Solutions, Inc. (LifeAgain), and a minority investment in Healthy Brands Collective. Angionetics is its subsidiary focused on late-stage clinical development and commercialization of Generx, which is an angiogenic gene therapy product candidate designed for medical revascularization for treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. Activation Therapeutics is its subsidiary focused on development and commercialization of Excellagen technology platform, which is a flowable dermal matrix for wound care that has application as a delivery platform for small molecule drugs, proteins and biologics.
Medicine Medical Specialties RTT Clinical Medicine Gene Therapy Coronary Artery Disease Aging Associated Diseases Angina Refractory Angina Revascularization

Is CRXM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.19
52 Week Low 0.0511
Average Volume 5,409
200-Day Moving Average 0.1378
50-Day Moving Average 0.1549
20-Day Moving Average 0.1687
10-Day Moving Average 0.1692
Average True Range 0.0525
ADX 61.29
+DI 4.9618
-DI 30.7525
Chandelier Exit (Long, 3 ATRs ) 0.0325
Chandelier Exit (Short, 3 ATRs ) 0.2275
Upper Bollinger Band 0.1925
Lower Bollinger Band 0.1449
Percent B (%b) 0.11
BandWidth 28.2158
MACD Line 0.0012
MACD Signal Line 0.0046
MACD Histogram -0.0033
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2100
Resistance 3 (R3) 0.2033 0.1767 0.2000
Resistance 2 (R2) 0.1767 0.1614 0.1800 0.1967
Resistance 1 (R1) 0.1633 0.1519 0.1700 0.1700 0.1933
Pivot Point 0.1367 0.1367 0.1400 0.1400 0.1367
Support 1 (S1) 0.1233 0.1214 0.1300 0.1300 0.1067
Support 2 (S2) 0.0967 0.1119 0.1000 0.1033
Support 3 (S3) 0.0833 0.0967 0.1000
Support 4 (S4) 0.0900